Activated Status and Altered Functions of Neutrophils in Poorly Controlled Diabetes
Abstract
Objectives. This study aimed to investigate the association of hyperglycemia and AGE on the phenotypes and biological functions of neutrophils to understand their roles in diabetes-related atherosclerosis.
Methodology. Healthy subjects (HS) (n=5) and type 2 diabetic patients grouped according to glycemic control [good control, HbA1c 7% or less, n=6 (well controlled diabetic, WCD); poor control, HbA1c more than 9%, n=6 (poorly controlled diabetic, PCD)] were included in the study. Neutrophils were isolated from peripheral venous blood samples. To determine in vitro effects of high glucose and AGE, neutrophils derived from HS were exposed to 5 mM glucose, 25 mM glucose, 100 μg/mL BSA and AGE-BSA. We determined basal and PMA-stimulated production of ROS, expression of CD11b and CD66b, release of MPO, cell migration to IL-8 and adhesion to an endothelial cell layer.
Results. In diabetic subjects, cells from WCD produced significantly higher basal and PMA-stimulated ROS (p=0.014), while cells from PCD showed significantly increased expression of CD11b, CD66b and MPO production (p=0.021, 0.034, 0.05, respectively). The release of MPO was significantly increased after PMA stimulation in cells incubated in AGE-BSA, compared to those incubated in unmodified BSA. We observed significantly enhanced migration towards IL-8 and adherence to endothelial cells in neutrophils exposed to high glucose.
Conclusions. Our findings indicate the activated status of neutrophils from diabetic patients. Neutrophils from healthy subjects exposed to conditions simulating hyperglycemia showed increased adhesive capacity. We made the novel finding of enhanced neutrophil migration toward IL-8 and adherence to endothelial cells upon exposure to high glucose conditions. These altered neutrophil functions may lead to the development and progression of atherosclerosis in diabetes.
Downloads
References
Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ. 2000;321(7258):405-12.
McLellan AC, Thornalley PJ, Benn J, et al. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sci (Lond). 1994;87(1):21-9.
Nin JW, Jorsal A, Ferreira I, et al. Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: A 12-year follow-up study. Diabetes Care. 2011;34(2):442-7.
Wada R, Yagihashi S. Role of advanced glycation end products and their receptors in development of diabetic neuropathy. Ann N Y Acad Sci. 2005;1043:598-604.
Al-Mesallamy HO, Hammad LN, El-Mamoun TA, et al. Role of advanced glycation end product receptors in the pathogenesis of diabetic retinopathy. J Diabetes Complications. 2011;25(3):168-74.
Collison KS, Parhar RS, Saleh SS, et al. RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs). J Leukoc Biol. 2002;71(3):433-44.
Mullarkey CJ, Edelstein D, Brownlee M. Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes. Biochem Biophys. Res Commun 1990;173(3):932-9.
Basta G, Lazzerini G, Massaro M, et al. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: A mechanism for amplification of inflammatory responses. Circulation. 2002;105(7):816-22.
Bonnardel-Phu E, Wautier JL, Schmidt AM, et al. Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo. Diabetes.1999;48(10):2052-8.
Horiuchi S, Sano H, Higashi T, et al. Extra- and intracellular localization of advanced glycation end-products in human atherosclerotic lesions. Nephrol Dial Transplant. 1996;11(Suppl 5):81-6.
Delamaire M, Maugendre D, Moreno M, et al. Impaired leucocyte functions in diabetic patients. Diabet Med. 1997;14(1):29-34.
Collins RG, Velji R, Guevara NV, et al. P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med. 2000;191(1):189-94.
Ruchaud-Sparagano MH, Stocks SC, Turley H, et al. Activation of neutrophil function via CD66: differential effects upon beta 2 integrin mediated adhesion. Br J Haematol. 1997;98(3):612-20.
Lau D, Mollnau H, Eiserich JP, et al. Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci USA. 2005;102(2):431-6.
van Leeuwen M, Gijbels MJ, Duijvestijn A, et al. Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR-/- mice. Arterioscler Thromb Vasc Biol. 2008;28(1):84-9.
Zhang R, Brennan ML, Fu X, et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA. 2001;286(17):2136-42.
Vowells SJ, Sekhsaria S, Malech HL, et al. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods. 1995;178(1):89-97.
Hand WL, Hand DL, Vasquez Y. Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes. Diabetes Res Clin Pract. 2007;76(1):44-50.
Du X, Matsumura T, Edelstein D, et al. Inhibition of GAPDH activity by poly (ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest. 2003;112(7):1049-57.
Bansal S, Siddarth M, Chawla D, et al. Advanced glycation end products enhance reactive oxygen and nitrogen species generation in neutrophils in vitro. Mol Cell Biochem. 2012;361(1-2):289-96.
Davey PC, Zuzel M, Kamiguti AS, et al. Activation-dependent proteolytic degradation of polymorphonuclear cells. Br J Haematol. 2000;111:934-42.
Grykiel K, Zozulińska D, Kostrzewa A, et al. [Evaluation of expression of polymorphonuclear neutrophil surface receptors in patients with type 1 diabetes]. Pol Arch Med Wewn. 2001;105:377-81.
van Oostrom AJ, van Wijk JP, Sijmonsma TP, et al. Increased expression of activation markers on monocytes and neutrophils in type 2 diabetes. Neth J Med. 2004;62(9):320-5.
Rao KM, Hatchell DL, Cohen HJ, et al. Alterations in stimulus-induced integrin expression in peripheral blood neutrophils of patients with diabetic retinopathy. Am J Med Sci. 1997;313:131-7.
Senior PA, Marshall SM, Thomas TH. Dysregulation of PMN antigen expression in Type 2 diabetes may reflect a generalized defect of exocytosis: Influence of hypertension and microalbuminuria. J Leukoc Biol. 1999;65(6):800-7.
Schröder AK, Uciechowski P, Fleischer D, et al. Crosslinking of CD66B on peripheral blood neutrophils mediates the release of interleukin-8 from intracellular storage. Hum Immunol. 2006;67(9):676-82.
Omi H, Okayama N, Shimizu M, et al. Participation of high glucose concentrations in neutrophil adhesion and surface expression of adhesion molecules on cultured human endothelial cells: Effect of antidiabetic medicines. J Diabetes Complications. 2002;16(3):201-8.
Daugherty A, Dunn JL, Rateri DL, et al. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest. 1994;94(1):437-44.
Loria V, Dato I, Graziani F, et al. Myeloperoxidase: A new biomarker of inflammation in ischemic heart disease and acute coronary syndromes. Mediators Inflamm. 2008; 2008:135625.
Hatanaka E, Monteagudo PT, Marrocos MS, et al. Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clin Exp Immunol. 2006;146:443-7.
Wiersma JJ, Meuwese MC, van Miert JN, et al. Diabetes mellitus type 2 is associated with higher levels of myeloperoxidase. Med Sci Monit. 2008;14(8):CR406-10.
Published
How to Cite
Issue
Section
License
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.
